Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
By Ludwig Burger FRANKFURT (Reuters) – Novartis breast cancer drug Kisqali cut the risk of recurrence by more than 25%…
Health
J&J secures dismissal of whistleblower case over misuse of confidential info
By Brendan Pierson (Reuters) – A federal appeals court, in a decision unsealed Wednesday, upheld the dismissal of a whistleblower…
US food aid could shrink under debt ceiling deal, hunger groups warn
By Leah Douglas WASHINGTON (Reuters) – Changes to the largest U.S. food aid program in the debt deal passed by…
U.S. regulation fears drive insurers’ climate alliance break-up
By Tommy Wilkes LONDON (Reuters) -The success of Republicans in triggering the break-up of a coalition of insurance firms aimed…
US FDA revokes emergency use authorization for J&J’s COVID vaccine
(Reuters) – The U.S. Food and Drug Administration said on Thursday it has revoked the emergency use authorization for Johnson…
Biden plans to pick former North Carolina health secretary to lead CDC – source
(Reuters) – U.S. President Joe Biden plans to select former North Carolina health secretary Mandy Cohen to lead the Centers…
FDA warns about safety risks of tailored weight-loss drugs
(Reuters) – The U.S. Food and Drug Administration (FDA) warned about the safety risks of using compounded or custom-made versions…
US to require patient data for payment of Leqembi, similar Alzheimer’s drugs
By Julie Steenhuysen (Reuters) -The U.S. Medicare health plan said on Thursday it would limit reimbursement for Eisai Co Ltd…
U.S. Supreme Court gives boost to whistleblowers in drug pricing case
By John Kruzel WASHINGTON (Reuters) – The U.S. Supreme Court on Thursday gave a boost to whistleblowers in their bid…
AstraZeneca drug combo gets US nod to treat a type of prostate cancer
(Reuters) – AstraZeneca said on Thursday that a combination of its cancer drug Lynparza and abiraterone has been approved in…